ar Cost Value d Value Value Portion) (Total) Gross IRR Adeza Biomedical Corporation Diagnostics & Infrastructure 1996 4.8 27.7 - 27.7 5.75 5.75 20.1% Allos Therapeutics, Inc. Therapeutics 1998 2.6 wD - 7.5 2.87 2.87 38.8% Aradigm Corporation Therapeutics 1994 2.8 15.3 - 15.3 5.45 5.45 39.3% AtheroGenics, Inc. Therapeutics 1996 3:8 7.1